The company provides a technology-driven marketplace for commercial real estate, offering office space aggregation, brokerage services, and AI-powered lead generation tools for property developers and corporate clients.
The company lacks a durable moat as evidenced by low average ROCE (3.6%) and ROE (3.5%). While they claim a technology edge through AI platforms, the business remains a highly competitive brokerage and service model with low barriers to entry and poor cash conversion.
Capital has been primarily used for the acquisition of related-party or newly formed subsidiaries (Brantford, Altrr, NES Data) via share swaps and preferential allotments. While these actions have inflated the balance sheet and net worth, they have yet to translate into meaningful cash flow or high returns on invested capital.
The company's rapid expansion through share-swap acquisitions of related-party entities proved to be a house of cards. While these transactions inflated the balance sheet and reported earnings, they failed to generate actual cash, as evidenced by the abysmal cash conversion rate. Over five years, the lack of a genuine competitive advantage led to stagnant returns on capital, and the market eventually realized the 'AI-driven' growth was merely a series of accounting maneuvers and preferential allotments rather than a sustainable business model.
RichFakir rates TCC Concept Ltd's business quality as mediocre — 43/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, TCC Concept Ltd is trading about 71% above our estimate of fair value; we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on TCC Concept Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of TCC Concept Ltd's fair value is about ₹24 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →